Shoulder Replacement Surgeries for Shoulder Osteoarthritis
(SERVASA15 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two types of shoulder replacement surgeries to determine which is more effective for individuals with severe shoulder arthritis. Total Shoulder Arthroplasty replaces the shoulder joint and uses a special component to address uneven bone. Reverse Shoulder Arthroplasty switches the position of the joint parts. The trial seeks participants aged 65 and older who have tried other treatments for at least six months but continue to experience pain and issues from shoulder arthritis. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance future treatment options for shoulder arthritis.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study involves surgical procedures, it's best to discuss your medications with the study team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both Reverse Shoulder Arthroplasty (RSA) and Total Shoulder Arthroplasty (TSA) with an enhanced glenoid component are generally safe options for shoulder surgery.
For RSA, studies have consistently found it reduces pain and improves movement, with long-term success rates remaining high. One study reported that 88% of patients did not need additional surgery within 10 years, indicating RSA is well-tolerated over time.
Regarding TSA, research indicates a low complication rate of 2.6% and an even lower rate of follow-up surgery at 1.9%. This suggests that TSA with an enhanced glenoid component is also a safe and effective option.
Overall, both surgeries have strong safety records, with only a small percentage of patients experiencing complications or needing further surgery.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for shoulder osteoarthritis because they offer innovative approaches to joint replacement. Total Shoulder Arthroplasty with an augmented glenoid component aims to improve joint stability and alignment by using artificial parts to compensate for missing bone, a step beyond standard shoulder replacements. On the other hand, Reverse Shoulder Arthroplasty flips the orientation of the ball and socket, potentially offering improved outcomes for patients whose shoulders are unstable. These techniques could lead to more effective and tailored solutions for those suffering from severe shoulder damage.
What evidence suggests that this trial's treatments could be effective for shoulder osteoarthritis?
Research shows that reverse shoulder replacement surgery, one of the treatments studied in this trial, can greatly improve shoulder movement and reduce pain compared to non-surgical treatments. Long-term studies indicate that 88% of patients do not need further surgery 10 years after the procedure. This surgery is especially beneficial for people aged 60 and older with shoulder arthritis.
In contrast, total shoulder replacement with an augmented glenoid component, another treatment option in this trial, also yields good results. Studies have found that this surgery improves shoulder function, with benefits lasting from 6 months to 5 years. Early research shows low rates of complications and the need for additional surgery, making it a promising option for treating shoulder problems.13567Who Is on the Research Team?
Peter Lapner, MD
Principal Investigator
The Ottawa Hospital
Are You a Good Fit for This Trial?
This trial is for people aged 65 and older with advanced shoulder osteoarthritis and a specific bone condition (over 15 degrees of glenoid retroversion). They must have tried standard treatments like painkillers, physiotherapy, and lifestyle changes for at least six months without success. Those who've had previous shoulder surgery or suffer from certain other conditions can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either Total Shoulder Arthroplasty (TSA) with an augmented glenoid component or Reverse Shoulder Arthroplasty (RSA) procedure
Follow-up
Participants are monitored for safety, effectiveness, and quality of life outcomes post-surgery
Long-term Follow-up
Participants' long-term outcomes are assessed, including quality of life and component survivorship
What Are the Treatments Tested in This Trial?
Interventions
- Reverse Shoulder Arthroplasty
- Total Shoulder Arthroplasty + augmented glenoid component
Trial Overview
The study is comparing two surgical procedures for severe shoulder arthritis: Total Shoulder Arthroplasty with an augmented component versus Reverse Shoulder Arthroplasty. It's designed to find out which surgery works better for patients with the specified bone condition in their shoulders.
How Is the Trial Designed?
2
Treatment groups
Active Control
TSA procedure involves replacing the worn-out ball and socket joint with prosthetic components. An additional surgical technique, "augmented glenoid component" implantation is performed when there is missing bone in the shoulder and is currently being done as standard of care. This technique is used particularly when a large amount of instability within the shoulder joint is present. This technique attempts to realign and restore balance to the shoulder joint using artificial components.
RSA procedure is similar to a TSA, however the orientation of the ball and socket joint is placed in the reverse position
Reverse Shoulder Arthroplasty is already approved in European Union, United States, Canada for the following indications:
- Massive rotator cuff tears
- Irreparable rotator cuff tears
- Severe shoulder arthritis
- Massive rotator cuff tears
- Irreparable rotator cuff tears
- Severe shoulder arthritis
- Failed rotator cuff repair
- Massive rotator cuff tears
- Irreparable rotator cuff tears
- Severe shoulder arthritis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor
Published Research Related to This Trial
Citations
Reverse total shoulder replacement versus anatomical ...
This study's findings provide reassurance that RTSR is an acceptable alternative to TSR for patients aged 60 years or older with osteoarthritis and intact ...
an analysis of data from the National Joint Registry
TSA resulted in superior OSSs at 6 months in patients with osteoarthritis. The median OSS improved from 6 months to 5 years following TSA; however, there was a ...
Shoulder replacement in the under 55's is anatomical or ...
Reverse shoulder replacement can be a viable solution for younger patients with severe shoulder pathology when anatomic TSA is not an option. ...
Long-Term Outcomes Following Reverse Total Shoulder ...
RTSA can provide satisfactory improvement of pain and function at long-term follow-up mean revision-free survivorship of 88% after 10 years.
Short- to medium-term outcomes and future direction of ...
Reverse shoulder arthroplasty is associated with significant improvements in shoulder function and pain reduction compared to non-surgical treatments.
Clinical outcomes after reverse shoulder arthroplasty in ...
Early published results of RTSA in elderly, low demand patients with cuff tear arthropathy noted reliable improvements in pain, range of motion, and overall ...
Total vs. Reverse Shoulder Replacement: Pain Relief Two ...
The Reverse Shoulder Arthroplasty has revolutionized the management of complex shoulder pain and dysfunction due to rotator cuff tear arthropathy since its FDA ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.